Certain New Chemicals or Significant New Uses; Statements of Findings for September 2021, 2430-2431 [2022-00643]

Download as PDF 2430 Federal Register / Vol. 87, No. 10 / Friday, January 14, 2022 / Notices Liaison Officer has been authorized to sign and submit the document in electronic format for publication, as an official document of the Department of Energy. This administrative process in no way alters the legal effect of this document upon publication in the Federal Register. Dated: January 12, 2022. Cindy S. Barger, Director, NEPA Compliance Division, Office of Federal Activities. Signed in Washington, DC, on January 11, 2022. Treena V. Garrett, Federal Register Liaison Officer, U.S. Department of Energy. ENVIRONMENTAL PROTECTION AGENCY [FR Doc. 2022–00668 Filed 1–13–22; 8:45 am] ENVIRONMENTAL PROTECTION AGENCY Environmental Protection Agency (EPA). ACTION: Notice. Responsible Agency: Office of Federal Activities, General Information 202– 564–5632 or https://www.epa.gov/nepa. Weekly receipt of Environmental Impact Statements (EIS) Filed January 3, 2022 10 a.m. EST Through January 10, 2022 10 a.m. EST Pursuant to 40 CFR 1506.9. Notice lotter on DSK11XQN23PROD with NOTICES1 The Toxic Substances Control Act (TSCA) requires EPA to publish in the Federal Register a statement of its findings after its review of certain TSCA notices when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to premanufacture notices (PMNs), microbial commercial activity notices (MCANs), and significant new use notices (SNUNs) submitted to EPA under TSCA. This document presents statements of findings made by EPA on such submissions during the period from September 1, 2021 to September 30, 2021. FOR FURTHER INFORMATION CONTACT: For technical information contact: Rebecca Edelstein, Chemical Control Division (7405M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: 202–564–1667; email address: Edelstein.rebecca@ epa.gov. For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@ epa.gov. SUMMARY: Environmental Impact Statements; Notice of Availability Section 309(a) of the Clean Air Act requires that EPA make public its comments on EISs issued by other Federal agencies. EPA’s comment letters on EISs are available at: https:// cdxnodengn.epa.gov/cdx-enepa-public/ action/eis/search. EIS No. 20220004, Final, APHIS, OR, ADOPTION—Final Bighorn Sheep Management Plan Environmental Impact Statement, Contact: Kevin Christensen 503–820–2751. The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) has adopted the U.S. Fish and Wildlife Service (USFWS) Final EIS No. 20210178, filed 11/23/ 2021 with the Environmental Protection Agency. The APHIS was a cooperating agency on this project. Therefore, republication of the document is not necessary under Section 1506.3(b)(2) of the CEQ regulations. EIS No. 20220005, Draft, DOE, NAT, Proposed Energy Conservation Standards for Manufactured Housing, Comment Period Ends: 02/28/2022, Contact: Roak Parker 240–562–1645. EIS No. 20220007, Final, USACE, LA, Upper Barataria Basin Louisiana Study, Review Period Ends: 02/14/ 2022, Contact: Patricia Naquin 504– 862–1544. Jkt 256001 [EPA–HQ–OPPT–2021–0146; FRL–8682–06– OCSPP] AGENCY: [ER–FRL–9060–3] 18:04 Jan 13, 2022 BILLING CODE 6560–50–P Certain New Chemicals or Significant New Uses; Statements of Findings for September 2021 BILLING CODE 6450–01–P VerDate Sep<11>2014 [FR Doc. 2022–00798 Filed 1–13–22; 8:45 am] SUPPLEMENTARY INFORMATION: I. General Information A. Does this action apply to me? This action is directed to the public in general. As such, the Agency has not attempted to describe the specific entities that this action may apply to. Although others may be affected, this action applies directly to the submitters of the PMNs addressed in this action. PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 B. How can I get copies of this document and other related information? The docket for this action, identified by docket identification (ID) number EPA–HQ–OPPT–2021–0146, is available at https://www.regulations.gov or at the Office of Pollution Prevention and Toxics Docket (OPPT Docket), Environmental Protection Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is (202) 566–1744, and the telephone number for the OPPT Docket is (202) 566–0280. Due to the public health concerns related to COVID–19, the EPA Docket Center (EPA/DC) and Reading Room is closed to visitors with limited exceptions. The staff continues to provide remote customer service via email, phone, and webform. For the latest status information on EPA/DC services and docket access, visit https:// www.epa.gov/dockets. II. What action is the Agency taking? This document lists the statements of findings made by EPA after review of notices submitted under TSCA section 5(a) that certain new chemical substances or significant new uses are not likely to present an unreasonable risk of injury to health or the environment. This document presents statements of findings made by EPA during the period from September 1, 2021 to September 30, 2021. III. What is the Agency’s authority for taking this action? TSCA section 5(a)(3) requires EPA to review a TSCA section 5(a) notice and make one of the following specific findings: • The chemical substance or significant new use presents an unreasonable risk of injury to health or the environment; • The information available to EPA is insufficient to permit a reasoned evaluation of the health and environmental effects of the chemical substance or significant new use; • The information available to EPA is insufficient to permit a reasoned evaluation of the health and environmental effects and the chemical substance or significant new use may present an unreasonable risk of injury to health or the environment; • The chemical substance is or will be produced in substantial quantities, and such substance either enters or may E:\FR\FM\14JAN1.SGM 14JAN1 Federal Register / Vol. 87, No. 10 / Friday, January 14, 2022 / Notices reasonably be anticipated to enter the environment in substantial quantities or there is or may be significant or substantial human exposure to the substance; or • The chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Unreasonable risk findings must be made without consideration of costs or other non-risk factors, including an unreasonable risk to a potentially exposed or susceptible subpopulation identified as relevant under the conditions of use. The term ‘‘conditions of use’’ is defined in TSCA section 3 to mean ‘‘the circumstances, as determined by the Administrator, under which a chemical substance is intended, known, or reasonably foreseen to be manufactured, processed, distributed in commerce, used, or disposed of.’’ EPA is required under TSCA section 5(g) to publish in the Federal Register a statement of its findings after its review of a TSCA section 5(a) notice EPA case No. J–21–0011 ......... P–21–0087 ......... IV. Statements of Administrator Findings Under TSCA Section 5(a)(3)(C) In this unit, EPA provides the following information (to the extent that such information is not claimed as Confidential Business Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this period, EPA has made findings under TSCA section 5(a)(3)(C) that the new chemical substances or significant new uses are not likely to present an unreasonable risk of injury to health or the environment: • EPA case number assigned to the TSCA section 5(a) notice. • Chemical identity (generic name if the specific name is claimed as CBI). • Website link to EPA’s decision document describing the basis of the ‘‘not likely to present an unreasonable risk’’ finding made by EPA under TSCA section 5(a)(3)(C). Website link Saccharomyces cerevisiae fermenting C5 sugars, modified (Generic Name). Syrups, hydrolyzed starch, dehydrated, polymers with methacrylic acid and alkenenylbenzene (Generic Name). Authority: 15 U.S.C. 2601 et seq. [FR Doc. 2022–00643 Filed 1–13–22; 8:45 am] BILLING CODE 6560–50–P FEDERAL COMMUNICATIONS COMMISSION [OMB 3060–0537; FR ID 66902] Information Collections Being Reviewed by the Federal Communications Commission Federal Communications Commission. ACTION: Notice and request for comments. AGENCY: As part of its continuing effort to reduce paperwork burdens, and as required by the Paperwork Reduction Act (PRA) of 1995, the Federal Communications Commission (FCC or Commission) invites the general public and other Federal agencies to take this opportunity to comment on the following information collections. Comments are requested concerning: Whether the proposed collection of SUMMARY: lotter on DSK11XQN23PROD with NOTICES1 notwithstanding any remaining portion of the applicable review period. Chemical identity Dated: January 5, 2022. Madison Le, Director, New Chemicals Division, Office of Pollution Prevention and Toxics. VerDate Sep<11>2014 when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to PMNs, MCANs, and SNUNs submitted to EPA under TSCA section 5. Anyone who plans to manufacture (which includes import) a new chemical substance for a non-exempt commercial purpose and any manufacturer or processor wishing to engage in a use of a chemical substance designated by EPA as a significant new use must submit a notice to EPA at least 90 days before commencing manufacture of the new chemical substance or before engaging in the significant new use. The submitter of a notice to EPA for which EPA has made a finding of ‘‘not likely to present an unreasonable risk of injury to health or the environment’’ may commence manufacture of the chemical substance or manufacture or processing for the significant new use 18:04 Jan 13, 2022 Jkt 256001 https://www.epa.gov/system/files/documents/2021-10/j-210011_determination_non-cbi_final.pdf. https://www.epa.gov/system/files/documents/2021-11/p-210087_determination_non-cbi_final.pdf. information is necessary for the proper performance of the functions of the Commission, including whether the information shall have practical utility; the accuracy of the Commission’s burden estimate; ways to enhance the quality, utility, and clarity of the information collected; ways to minimize the burden of the collection of information on the respondents, including the use of automated collection techniques or other forms of information technology; and ways to further reduce the information collection burden on small business concerns with fewer than 25 employees. The FCC may not conduct or sponsor a collection of information unless it displays a currently valid OMB control number. No person shall be subject to any penalty for failing to comply with a collection of information subject to the PRA that does not display a valid OMB control number. Written PRA comments should be submitted on or before March 15, 2022. If you anticipate that you will be submitting comments but find it difficult to do so within the period of time allowed by this notice, you should advise the contact listed below as soon as possible. DATES: PO 00000 Frm 00029 2431 Fmt 4703 Sfmt 4703 Direct all PRA comments to Cathy Williams, FCC, via email to PRA@ fcc.gov and to Cathy.Williams@fcc.gov. FOR FURTHER INFORMATION CONTACT: For additional information about the information collection, contact Cathy Williams at (202) 418–2918. SUPPLEMENTARY INFORMATION: OMB Control Number: 3060–0537. Title: Sections 13.9(c), 13.13(c), 13.17(b), 13.211(e) and 13.217, Commercial Operator License Examination Managers (COLEM) Records. Form Number: N/A. Type of Review: Extension of a currently approved collection. Respondents: Business or other forprofit entities. Number of Respondents: 659 respondents; 659 responses. Estimated Time per Response: .44 hours to 30 hours. Frequency of Response: Recordkeeping requirement and on occasion reporting requirement. Obligation to Respond: Required to obtain or retain benefits. Statutory authority for this information collection is contained in 47 U.S.C. 154 and 303 of the Communications Act of 1934. Total Annual Burden: 14,796 hours. Total Annual Cost: No cost. ADDRESSES: E:\FR\FM\14JAN1.SGM 14JAN1

Agencies

[Federal Register Volume 87, Number 10 (Friday, January 14, 2022)]
[Notices]
[Pages 2430-2431]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00643]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2021-0146; FRL-8682-06-OCSPP]


Certain New Chemicals or Significant New Uses; Statements of 
Findings for September 2021

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Toxic Substances Control Act (TSCA) requires EPA to 
publish in the Federal Register a statement of its findings after its 
review of certain TSCA notices when EPA makes a finding that a new 
chemical substance or significant new use is not likely to present an 
unreasonable risk of injury to health or the environment. Such 
statements apply to premanufacture notices (PMNs), microbial commercial 
activity notices (MCANs), and significant new use notices (SNUNs) 
submitted to EPA under TSCA. This document presents statements of 
findings made by EPA on such submissions during the period from 
September 1, 2021 to September 30, 2021.

FOR FURTHER INFORMATION CONTACT: 
    For technical information contact: Rebecca Edelstein, Chemical 
Control Division (7405M), Office of Pollution Prevention and Toxics, 
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, 
DC 20460-0001; telephone number: 202-564-1667; email address: 
[email protected].
    For general information contact: The TSCA-Hotline, ABVI-Goodwill, 
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 
554-1404; email address: [email protected].

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    This action is directed to the public in general. As such, the 
Agency has not attempted to describe the specific entities that this 
action may apply to. Although others may be affected, this action 
applies directly to the submitters of the PMNs addressed in this 
action.

B. How can I get copies of this document and other related information?

    The docket for this action, identified by docket identification 
(ID) number EPA-HQ-OPPT-2021-0146, is available at https://www.regulations.gov or at the Office of Pollution Prevention and Toxics 
Docket (OPPT Docket), Environmental Protection Agency Docket Center 
(EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301 
Constitution Ave. NW, Washington, DC. The Public Reading Room is open 
from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal 
holidays. The telephone number for the Public Reading Room is (202) 
566-1744, and the telephone number for the OPPT Docket is (202) 566-
0280.
    Due to the public health concerns related to COVID-19, the EPA 
Docket Center (EPA/DC) and Reading Room is closed to visitors with 
limited exceptions. The staff continues to provide remote customer 
service via email, phone, and webform. For the latest status 
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.

II. What action is the Agency taking?

    This document lists the statements of findings made by EPA after 
review of notices submitted under TSCA section 5(a) that certain new 
chemical substances or significant new uses are not likely to present 
an unreasonable risk of injury to health or the environment. This 
document presents statements of findings made by EPA during the period 
from September 1, 2021 to September 30, 2021.

III. What is the Agency's authority for taking this action?

    TSCA section 5(a)(3) requires EPA to review a TSCA section 5(a) 
notice and make one of the following specific findings:
     The chemical substance or significant new use presents an 
unreasonable risk of injury to health or the environment;
     The information available to EPA is insufficient to permit 
a reasoned evaluation of the health and environmental effects of the 
chemical substance or significant new use;
     The information available to EPA is insufficient to permit 
a reasoned evaluation of the health and environmental effects and the 
chemical substance or significant new use may present an unreasonable 
risk of injury to health or the environment;
     The chemical substance is or will be produced in 
substantial quantities, and such substance either enters or may

[[Page 2431]]

reasonably be anticipated to enter the environment in substantial 
quantities or there is or may be significant or substantial human 
exposure to the substance; or
     The chemical substance or significant new use is not 
likely to present an unreasonable risk of injury to health or the 
environment.
    Unreasonable risk findings must be made without consideration of 
costs or other non-risk factors, including an unreasonable risk to a 
potentially exposed or susceptible subpopulation identified as relevant 
under the conditions of use. The term ``conditions of use'' is defined 
in TSCA section 3 to mean ``the circumstances, as determined by the 
Administrator, under which a chemical substance is intended, known, or 
reasonably foreseen to be manufactured, processed, distributed in 
commerce, used, or disposed of.''
    EPA is required under TSCA section 5(g) to publish in the Federal 
Register a statement of its findings after its review of a TSCA section 
5(a) notice when EPA makes a finding that a new chemical substance or 
significant new use is not likely to present an unreasonable risk of 
injury to health or the environment. Such statements apply to PMNs, 
MCANs, and SNUNs submitted to EPA under TSCA section 5.
    Anyone who plans to manufacture (which includes import) a new 
chemical substance for a non-exempt commercial purpose and any 
manufacturer or processor wishing to engage in a use of a chemical 
substance designated by EPA as a significant new use must submit a 
notice to EPA at least 90 days before commencing manufacture of the new 
chemical substance or before engaging in the significant new use.
    The submitter of a notice to EPA for which EPA has made a finding 
of ``not likely to present an unreasonable risk of injury to health or 
the environment'' may commence manufacture of the chemical substance or 
manufacture or processing for the significant new use notwithstanding 
any remaining portion of the applicable review period.

IV. Statements of Administrator Findings Under TSCA Section 5(a)(3)(C)

    In this unit, EPA provides the following information (to the extent 
that such information is not claimed as Confidential Business 
Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this 
period, EPA has made findings under TSCA section 5(a)(3)(C) that the 
new chemical substances or significant new uses are not likely to 
present an unreasonable risk of injury to health or the environment:
     EPA case number assigned to the TSCA section 5(a) notice.
     Chemical identity (generic name if the specific name is 
claimed as CBI).
     Website link to EPA's decision document describing the 
basis of the ``not likely to present an unreasonable risk'' finding 
made by EPA under TSCA section 5(a)(3)(C).

------------------------------------------------------------------------
      EPA case No.          Chemical identity          Website link
------------------------------------------------------------------------
J-21-0011..............  Saccharomyces            https://www.epa.gov/
                          cerevisiae fermenting    system/files/
                          C5 sugars, modified      documents/2021-10/j-
                          (Generic Name).          21-
                                                   0011_determination_no
                                                   n-cbi_final.pdf.
P-21-0087..............  Syrups, hydrolyzed       https://www.epa.gov/
                          starch, dehydrated,      system/files/
                          polymers with            documents/2021-11/p-
                          methacrylic acid and     21-
                          alkenenylbenzene         0087_determination_no
                          (Generic Name).          n-cbi_final.pdf.
------------------------------------------------------------------------

    Authority: 15 U.S.C. 2601 et seq.

    Dated: January 5, 2022.
Madison Le,
Director, New Chemicals Division, Office of Pollution Prevention and 
Toxics.
[FR Doc. 2022-00643 Filed 1-13-22; 8:45 am]
BILLING CODE 6560-50-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.